Understanding Cholesterol: LDL, HDL and Non-HDL Explained
What is LDL cholesterol? Is HDL really good cholesterol? Consultant Radiologist Dr Prashant Bamania explains cholesterol results, non-HDL cholesterol, cardiovascular risk and what you can do about it.
Medically reviewed by: Dr Prashant Bamania, Consultant Radiologist
Last medically reviewed: 29 August 2026
At a glance
- Cholesterol itself is essential for normal human biology.
- The problem is not that the body contains cholesterol. The problem is that too many cholesterol-containing atherogenic particles circulating in the blood can enter artery walls and contribute to atherosclerosis.
- The terms you are most likely to see on a blood test are: total cholesterol, LDL cholesterol, HDL cholesterol, non-HDL cholesterol and triglycerides.
- Your cholesterol result should be interpreted as part of your overall cardiovascular risk — not as an isolated number.
- Current NHS and NICE guidance uses cholesterol alongside factors such as age, blood pressure, smoking, diabetes and other health conditions when assessing cardiovascular risk.[1,2]
What is cholesterol?
Cholesterol is a waxy substance used by the body for important functions, including:
- cell membranes
- steroid-hormone production
- bile-acid production.
Because fats do not dissolve easily in blood, cholesterol and triglycerides travel through the circulation packaged inside particles called lipoproteins.
Different lipoproteins have different roles and associations with cardiovascular disease.
What is LDL cholesterol?
LDL stands for: low-density lipoprotein.
LDL particles transport cholesterol around the body.
When the concentration of LDL-containing atherogenic particles is too high, particles can enter the artery wall and contribute to development of atherosclerotic plaque.
The evidence linking LDL to atherosclerotic cardiovascular disease is exceptionally strong. Genetic studies, epidemiological studies and randomised clinical trials consistently demonstrate that higher cumulative exposure to LDL increases atherosclerotic cardiovascular risk and that lowering LDL reduces cardiovascular events.[3,4]
This is why LDL is often referred to as: “bad cholesterol.”
That phrase is easy to understand, although technically LDL is a lipoprotein particle rather than cholesterol itself.
Does LDL actually cause heart disease?
Yes.
This is stronger than simply saying LDL is “associated” with heart disease.
A major European Atherosclerosis Society consensus review examined genetic, epidemiological and clinical-trial evidence involving millions of participants and concluded that LDL is a causal factor in atherosclerotic cardiovascular disease.[3]
The relationship also appears cumulative: both how high LDL is and how long someone is exposed to elevated LDL matter.
This is one reason cardiovascular prevention should ideally begin before significant disease develops.
What is HDL cholesterol?
HDL stands for: high-density lipoprotein.
HDL has traditionally been called: “good cholesterol.”
Higher HDL levels are associated observationally with lower cardiovascular risk.
However, the biology is more complicated than: “The higher my HDL, the healthier I am.”
Human genetic and randomised-trial evidence has challenged the idea that simply increasing the concentration of HDL cholesterol necessarily reduces cardiovascular events.[5,6]
So while HDL remains useful as part of cardiovascular-risk assessment, raising HDL itself is not generally the central therapeutic target in the way lowering LDL-containing atherogenic particles is.
So is HDL not important?
It is still useful.
A very low HDL level can be associated with an adverse metabolic and cardiovascular-risk profile.
But you should not interpret a high HDL as cancelling out:
- high LDL
- smoking
- high blood pressure
- diabetes
- obesity
- other cardiovascular risks.
Likewise, trying to artificially increase an HDL number is not equivalent to treating the underlying causes of cardiovascular risk.
What is non-HDL cholesterol?
Non-HDL cholesterol is calculated very simply: Total cholesterol − HDL cholesterol = non-HDL cholesterol.
It represents cholesterol carried in the range of atherogenic lipoproteins that can contribute to plaque formation.
This includes:
- LDL
- very-low-density lipoproteins
- intermediate-density lipoproteins
- remnant particles
- lipoprotein(a).
This is why non-HDL cholesterol can be particularly useful. It captures a broader range of atherogenic cholesterol than LDL cholesterol alone.
Why does NICE use non-HDL cholesterol?
Current NICE guidance uses non-HDL cholesterol in several important ways.
For people receiving statins for primary prevention, NICE recommends aiming for a greater than 40% reduction in non-HDL cholesterol.[2]
Non-HDL therefore provides a practical way to measure the overall response of atherogenic cholesterol to treatment.
Evidence also supports non-HDL cholesterol as an important marker of cardiovascular risk.[7,8]
What is total cholesterol?
Total cholesterol is the combined cholesterol contained within several different lipoprotein fractions.
It is useful, but by itself gives an incomplete picture.
Two people could have the same total cholesterol but very different:
- HDL
- non-HDL
- LDL
- triglycerides
- overall cardiovascular risks.
This is why clinicians increasingly look at a full lipid profile rather than total cholesterol alone.
What are triglycerides?
Triglycerides are another form of fat carried within the blood.
They are influenced by factors including:
- diet
- alcohol
- body weight
- diabetes
- genetics
- certain medications.
Very high triglyceride levels can create additional medical risks, while more moderate elevations may accompany an adverse metabolic and cardiovascular profile.
They should be interpreted alongside the rest of the lipid profile.
What cholesterol numbers are considered healthy?
For generally healthy adults, the NHS currently provides guide values including:
- total cholesterol: below 5 mmol/L
- HDL: above 1.0 mmol/L in men and above 1.2 mmol/L in women
- non-HDL: below 4 mmol/L.[1]
Someone who has already had a heart attack, stroke or established coronary artery disease will usually require a more intensive risk-reduction strategy than a young person with otherwise very low cardiovascular risk.
Is a cholesterol of 6 mmol/L dangerous?
A total cholesterol value cannot answer that question by itself.
Doctors would want to know:
- LDL
- HDL
- non-HDL
- triglycerides
- age
- blood pressure
- smoking status
- diabetes status
- kidney function
- family history
- other health conditions
- whether cardiovascular disease is already present.
That information can then be incorporated into an overall cardiovascular-risk assessment.
What is QRISK3?
QRISK3 is a UK risk calculator that estimates a person's probability of developing cardiovascular disease over the next 10 years.
It incorporates cholesterol together with many other factors.
This means two people with identical cholesterol results may have very different estimated cardiovascular risk.
Related article: What Is QRISK3 and What Does Your Cardiovascular Risk Mean?
When are statins recommended?
For primary prevention in the UK, NICE recommends offering atorvastatin 20 mg to many people whose QRISK3 10-year cardiovascular risk is 10% or greater, following appropriate discussion.[2]
Treatment can also be appropriate in other situations, including when the calculated risk may underestimate someone's true risk.
People with established cardiovascular disease are managed differently because they are already known to be at high cardiovascular risk.
How much does lowering LDL help?
A major Cholesterol Treatment Trialists' Collaboration meta-analysis involving approximately 170,000 participants across 26 randomised trials found that further LDL reduction produced further reductions in major vascular events.[4]
The benefit is related to:
- the amount LDL is lowered
- the individual's baseline cardiovascular risk
- duration of treatment.
This is why the same cholesterol reduction may produce a larger absolute benefit in someone at high baseline risk than in someone at very low risk.
Does everyone with high cholesterol need medication?
No.
Treatment depends on the person's overall risk and circumstances.
Management may include:
- lifestyle change alone
- lifestyle change plus medication
- investigation for an underlying cause
- assessment for an inherited lipid disorder.
NICE recommends optimising modifiable lifestyle and cardiovascular risk factors as part of primary prevention, while recognising that medication may also provide substantial benefit when indicated.[2]
What lifestyle changes help cholesterol?
Reduce saturated fat
Replacing some saturated fats with unsaturated fats can improve the lipid profile.
Increase fibre
Foods rich in soluble fibre can help lower LDL cholesterol.
Exercise regularly
Physical activity improves cardiovascular health even when changes in cholesterol itself are relatively modest.
Maintain a healthy weight
Where appropriate, weight reduction can improve several cardiovascular and metabolic risk factors.
Do not smoke
Smoking dramatically increases cardiovascular risk independently of cholesterol.
Manage diabetes and blood pressure
Cardiovascular risk factors frequently occur together. The goal is therefore not simply to “fix cholesterol” while ignoring everything else.
What about eggs?
For most people, blood LDL concentration is influenced more substantially by the overall dietary pattern, genetics and saturated-fat intake than by avoiding individual cholesterol-containing foods alone.
Dietary recommendations should therefore focus on the whole eating pattern rather than labelling one food as universally “good” or “bad”.
People with specific lipid disorders may need individualised advice.
What is familial hypercholesterolaemia?
Familial hypercholesterolaemia (FH) is an inherited condition that causes markedly raised LDL cholesterol from a young age.
Because the arteries are exposed to high LDL for many years, untreated FH substantially increases premature cardiovascular risk.
NICE recommends considering the full lipid profile, clinical findings and family history when deciding whether an inherited lipid disorder may be present.[2]
Current NICE guidance recommends specialist assessment in people with particularly extreme lipid levels, including total cholesterol above 9.0 mmol/L or non-HDL cholesterol above 7.5 mmol/L, even without a first-degree family history of premature coronary disease.[2]
What is lipoprotein(a)?
Lipoprotein(a), or Lp(a), is another atherogenic lipoprotein whose concentration is largely genetically determined.
It is not included routinely in every standard lipid profile.
Testing may be useful in selected people, particularly where there is premature cardiovascular disease or a strong family history.
A future Live, Onward article will explain Lp(a) in more detail.
Should I worry about cholesterol if I exercise and feel healthy?
Being fit is extremely beneficial.
But fitness does not make somebody immune to:
- genetic lipid disorders
- hypertension
- diabetes
- coronary atherosclerosis.
Likewise, somebody can feel completely well while cardiovascular risk factors develop silently.
This is why prevention focuses on identifying modifiable risk before a heart attack or stroke occurs.
Can cholesterol plaque be seen on a scan?
Yes.
Imaging can sometimes demonstrate the consequences of atherosclerotic cholesterol-containing plaque.
For example:
- Coronary calcium CT — shows calcified coronary atherosclerosis.
- CT coronary angiography — can demonstrate calcified and non-calcified coronary plaque and assess narrowing of the coronary arteries.
However, imaging and blood tests answer different questions.
A normal scan today does not mean cardiovascular risk factors should be ignored indefinitely.
Questions to ask when you get a cholesterol result
Rather than asking only: “Is my cholesterol high?” consider asking:
- What is my LDL cholesterol?
- What is my non-HDL cholesterol?
- What are my triglycerides?
- What is my QRISK3 score?
- What is my blood pressure?
- Is my family history important?
- Could this represent familial hypercholesterolaemia?
- Would lifestyle changes be enough?
- What would I gain from medication?
- What target or percentage reduction are we aiming for?
The key message
LDL and other atherogenic lipoproteins matter because they contribute directly to the development of atherosclerosis.
But good cardiovascular prevention is about much more than one cholesterol result.
The goal is to understand: your cholesterol + your blood pressure + your lifestyle + your medical history + your overall cardiovascular risk — and then reduce the risks that can be changed.
What does the evidence say?
LDL and other atherogenic lipoproteins contribute directly to atherosclerosis. Genetic, epidemiological and randomised-trial evidence consistently show that higher cumulative exposure to LDL increases cardiovascular risk and that lowering LDL reduces major vascular events in proportion to the reduction achieved.[3,4]
Non-HDL cholesterol captures a broader range of atherogenic cholesterol than LDL alone and is used by NICE to assess treatment response, with a recommended greater than 40% reduction in people receiving statins for primary prevention.[2,7,8]
HDL is observationally associated with cardiovascular risk, but simply raising HDL cholesterol has not consistently reduced cardiovascular events in genetic studies or randomised trials.[5,6]
Video explainer
Video coming soon
Coming soon: Dr Prash explains LDL, HDL and non-HDL cholesterol using a simple visual model — and why “good vs bad cholesterol” doesn't tell the whole story.
Captions and a transcript will be published with each video.
Trusted resources
- NHSHigh cholesterol — NHS overview
- NICECardiovascular disease: risk assessment and reduction (NG238)
- British Heart FoundationHeart health information
- HEART UKCholesterol and lipid disorders
External links are provided as trusted resources. Live, Onward is not responsible for third-party content.
References
- 1.NHS. High cholesterol — cholesterol levels. 2026. View guidanceCurrent page reviewed 13 March 2026. General healthy-adult guide values include total cholesterol below 5 mmol/L, HDL above 1.0 mmol/L in men or 1.2 mmol/L in women, and non-HDL below 4 mmol/L.
- 2.National Institute for Health and Care Excellence (NICE). Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guideline NG238. 2023. View guidancePublished 2023; reviewed 2025
- 3.Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. European Heart Journal. 2017;38(32):2459–2472. DOI: 10.1093/eurheartj/ehx144. PMID: 28444290. View on PubMed View DOI
- 4.Cholesterol Treatment Trialists' Collaboration; Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–1681. DOI: 10.1016/S0140-6736(10)61350-5. PMID: 21067804. View on PubMed View DOI
- 5.Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet. 2012. PMID: 22607825. View on PubMed
- 6.Frikke-Schmidt R. HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease — insights from randomized clinical trials and human genetics. . 2021. PMID: 34637926. View on PubMed
- 7.Cao Y, Yan L, Guo N, et al. Non-high-density lipoprotein cholesterol and risk of cardiovascular disease in the general population and patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Research and Clinical Practice. 2019. PMID: 30448450. View on PubMed
- 8.Johannesen CDL, Langsted A, Nordestgaard BG, Mortensen MB. Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease. JAMA Cardiology. 2026;11(7):669–673. DOI: 10.1001/jamacardio.2026.0898. PMID: 42126847. View on PubMed View DOI
Evidence status
- Medically reviewed by:
- Dr Prashant Bamania, Consultant Radiologist
- Last medically reviewed:
- 29 August 2026
- Next review due:
- 29 August 2027
- Evidence last searched:
- 29 August 2026
Related reading
- What Is QRISK3 and What Does Your Cardiovascular Risk Mean?Read more
- Coronary Artery Calcium Score: What Does It Actually Mean?Read more
- CT Coronary Angiography: What It Shows and What to ExpectRead more
- High Blood Pressure Explained: What Do Your Blood Pressure Numbers Mean?Read more
- /heart/lipoprotein-aComing soon
- /heart/exercise-heart-healthComing soon
- /heart/statins-explainedComing soon